MoonLake Immunotherapeutics Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX

Core Viewpoint - DJS Law Group is investigating claims against MoonLake Immunotherapeutics for potential violations of securities laws, particularly related to misleading statements about its VELA-2 clinical trial [1][2]. Investigation Details - The investigation centers on whether MoonLake made misleading statements or failed to disclose critical information to investors. The company's communications regarding the VELA-2 clinical trial were deemed overly optimistic until September 29, 2025, when it announced that unexpected events in the placebo group prevented the study from achieving statistical significance in its primary endpoint, resulting in a 90% decline in share value [2]. Company Background - MoonLake Immunotherapeutics is a publicly traded company on NASDAQ under the ticker MLTX. The company is currently facing scrutiny due to the recent developments in its clinical trial results [1]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing sophisticated hedge funds and alternative asset managers. The firm emphasizes the importance of protecting investor rights and maximizing returns through legal advocacy [4].